Sequana Medical NV
XBRU:SEQUA

Watchlist Manager
Sequana Medical NV Logo
Sequana Medical NV
XBRU:SEQUA
Watchlist
Price: 0.85 EUR -1.16% Market Closed
Market Cap: 34.4m EUR
Have any thoughts about
Sequana Medical NV?
Write Note

Wall Street
Price Targets

SEQUA Price Targets Summary
Sequana Medical NV

Wall Street analysts forecast SEQUA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SEQUA is 4.31 EUR with a low forecast of 2.93 EUR and a high forecast of 6.3 EUR.

Lowest
Price Target
2.93 EUR
245% Upside
Average
Price Target
4.31 EUR
407% Upside
Highest
Price Target
6.3 EUR
641% Upside
Sequana Medical NV Competitors:
Price Targets
SOON
Sonova Holding AG
5% Downside
SRTS
Sensus Healthcare Inc
29% Upside
VANI
Vivani Medical Inc
319% Upside
BIOBV
Biohit Oyj
20% Upside
TNDM
Tandem Diabetes Care Inc
77% Upside
TMDX
Transmedics Group Inc
77% Upside
MASI
Masimo Corp
0% Downside
SHL
Siemens Healthineers AG
21% Upside

Revenue
Forecast

Revenue Estimate
Sequana Medical NV

For the last 7 years the compound annual growth rate for Sequana Medical NV's revenue is -10%. The projected CAGR for the next 3 years is 186%.

-10%
Past Growth
186%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sequana Medical NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Sequana Medical NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SEQUA's stock price target?
Price Target
4.31 EUR

According to Wall Street analysts, the average 1-year price target for SEQUA is 4.31 EUR with a low forecast of 2.93 EUR and a high forecast of 6.3 EUR.

What is Sequana Medical NV's Revenue forecast?
Projected CAGR
186%

For the last 7 years the compound annual growth rate for Sequana Medical NV's revenue is -10%. The projected CAGR for the next 3 years is 186%.

Back to Top